I presented Novartis (NVS) to the club on the 17th and we made a purchase on the 18th. Novartis is the currently the world's fourth-largest pharmaceutical company. It is Swiss-based and is traded as a deposit receipt here in the states. It made sense for our group since we did not yet have any positions in the pharmaceutical industry and it gives us a valuable hedge against the dollar. NVS is denominated to the Swiss franc, one of the most stable currencies in the world. Given the absolute monkeys we have managing US fiscal policy right now it is widely believed that the dollar will continue to deflate against some of the stronger currencies for the foreseeable future (at least for the next several years).
The pharmaceutical business is really driven by the following demands:
1) aging of the world's population
2) increased pace of technological discovery and development
3) quickly industrializing countries like India, China and Russia which are greatly increasing the availability of healthcare to their populations.
Novartis addresses all three very directly. I have posted a link to the research I presented to our group. It is available for download here.
0 Responses to “Club Buy: Novartis (NVS): $55.94: 20060418”